Genetic variants associated with severe retinopathy of prematurity in extremely low birth weight infants

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 10, 2014, Pages 6194-6203

  Hartnett, M Elizabeth ^a   Morrison, Margaux A ^a   Smith, Silvia ^a   Yanovitch, Tammy L ^b   Young, Terri L ^c   Colaizy, Tarah ^d   Momany, Allison ^d   Dagle, John ^d   Carlo, Waldemar A ^e   Clark, Erin A S ^a   Page, Grier ^f   Murray, Jeff ^d   DeAngelis, Margaret M ^a   Cotten, C Michael ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e University of Alabama at Birmingham   (United States)

^f Triangle Medical Research   (United States)

Author keywords

Brain derived neurotrophic factor; Extremely low birth weight; Genetic associations; Neurovascular; Retinopathy of prematurity

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GENOMIC DNA; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; DNA;

ALLELE; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; COHORT ANALYSIS; DRIED BLOOD SPOT TESTING; EXTREMELY LOW BIRTH WEIGHT; EYE EXAMINATION; FEMALE; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HUMAN; INFANT; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NERVE CELL DIFFERENTIATION; OXIDATION; PHENOTYPE; PLESIOMORPHY; RETROLENTAL FIBROPLASIA; RISK FACTOR; SEIZURE; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL FOR DATE INFANT; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; FOLLOW UP; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETICS; GESTATIONAL AGE; INCIDENCE; METABOLISM; NEWBORN; PREMATURITY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; UNITED STATES;

BRAIN-DERIVED NEUROTROPHIC FACTOR; DNA; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GENETIC VARIATION; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, GENETIC; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84908093474     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14841     Document Type: Article

References (44)

1. Zin A, Gole GA. Retinopathy of prematurity-incidence today. Clin Perinatol. 2013;40:185–200.
2. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008;84:77–82.
3. Patz A. Studies on retinal neovascularisation. Invest Ophthalmol Vis Sci. 1980;19:1133–1138.
4. York JR, Landers S, Kirby RS, Arbogast PG, Penn JS. Arterial oxygen fluctuation and retinopathy of prematurity in very-lowbirth- weight infants. J Perinatol. 2004;24:82–87.
5. Gagliardi L, Rusconi F, Da Fre M, et al. Pregnancy disorders leading to very preterm birth influence neonatal outcomes: results of the population-based ACTION cohort study. Pediatr Res. 2013;73:794–801.
6. Saunders RA, Donahue ML, Christmann LM, et al. Racial variation in retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1997;115:604–608.
7. Schaffer DB, Palmer EA, Plotsky DF, et al. Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology. 1993;100:230–237.
8. Ng YK, Fielder AR, Shaw DE, Levene MI. Epidemiology of retinopathy of prematurity. Lancet. 1988;1235–1238.
9. Darlow BA, Hutchinson JL, Henderson-Smart DJ, et al. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network. Pediatrics. 2005;115:990–996.
10. Bizzarro MJ, Hussain N, Jonsson B, et al. Genetic susceptibility to retinopathy of prematurity. Pediatrics. 2006;118:1858–1863.
11. Drenser KA, Dailey W, Vinekar A, Dalal K, Capone A Jr, Trese MT. Clinical presentation and genetic correlation of patients with mutations affecting the FZD4 gene. Arch Ophthalmol. 2009;127:1649–1654.
12. Hiraoka M, Takahashi H, Orimo H, Hiraoka M, Ogata T, Azuma N. Genetic screening of Wnt signaling factors in advanced retinopathy of prematurity. Mol Vis. 2010;16:2572–2577.
13. Kondo H, Kusaka S, Yoshinaga A, Uchio E, Tawara A, Tahira T. Genetic variants of FZD4 and LRP5 genes in patients with advanced retinopathy of prematurity. Mol Vis. 2013;19:476–485.
14. Ells A, Guernsey DL, Wallace K, et al. Severe retinopathy of prematurity associated with FZD4 mutations. Ophthalmic Genet. 2010;31:37–43.
15. Hiraoka M, Berinstein DM, Trese MT, Shastry BS. Insertion and deletion mutations in the dinucleotide repeat region of the Norrie disease gene in patients with advanced retinopathy of prematurity. J Hum Genet. 2001;46:179–181.
16. Shastry BS, Pendergast SD, Hartzer MK, Liu X, Trese MT. Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol. 1997;115:651–655.
17. MacDonald ML, Goldberg YP, Macfarlane J, Samuels ME, Trese MT, Shastry BS. Genetic variants of frizzled-4 gene in familial exudative vitreoretinopathy and advanced retinopathy of prematurity. Clin Genet. 2005;67:363–366.
18. Mohamed S, Schaa K, Cooper ME, et al. Genetic contributions to the development of retinopathy of prematurity. Pediatr Res. 2009;65:193–197.
19. Liu P, Wu D, Zhou W, et al. Association of VEGF gene polymorphisms with advanced retinopathy of prematurity: a meta-analysis. Mol Biol Rep. 2012;39:10731–10737.
20. Giusti B, Vestrini A, Poggi C, et al. Genetic polymorphisms of antioxidant enzymes as risk factors for oxidative stressassociated complications in preterm infants. Free Radic Res. 2012;46:1130–1139.
21. Poggi C, Giusti B, Vestri A, Pasquini E, Abbate R, Dani C. Genetic polymorphisms of antioxidant enzymes in preterm infants. J Matern Fetal Neonatal Med. 2012;25(suppl 4):131–134.
22. Shah PK, Narendran V, Kalpana N. Aggressive posterior retinopathy of prematurity in large preterm babies in South India. Arch Dis Child Fetal Neonatal Ed. 2012;97:F371–F375.
23. Good WV, Hardy RJ, Dobson V, et al. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics. 2005;116:15–23.
24. Multicentre trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1988;106:471–479.
25. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121: 1684–1694.
26. Carlo WA, McDonald SA, Tyson JE, et al. Cytokines and neurodevelopmental outcomes in extremely low birth weight infants. J Pediatr. 2011;159:919–925, e3.
27. Fierson WM. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2013;131:189–195.
28. Hartnett ME, Penn JS. Mechanisms and management of retinopathy of prematurity. New Engl J Med. 2012;367: 2515–2526.
29. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–575.
30. Gao X, Starmer J, Martin ER. A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol. 2008;32:361–369.
31. Patterson N, Price AL, Reich D. Population structure and eigenanalysis. PLoS Genet. 2006;2:e190.
32. Cotten CM, Page G, Carlo W, Higgins R, Murray JC. Genomewide association study of morbidities of extreme prematurity. Paper presented at: Pediatric Academic Societies Annual Meeting; April 28–May 1, 2012; Boston, MA. Abstract 4526. 381.
33. Verhoeven VJ, Hysi PG, Wojciechowski R, et al. Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet. 2013;45:314–318.
34. Sood BG, Madan A, Saha S, et al. Perinatal systemic inflammatory response syndrome and retinopathy of prematurity. Pediatr Res. 2010;67:394–400.
35. Fukushima Y, Okada M, Kataoka H, et al. Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice. J Clin Invest. 2011;121:1974–1985.
36. Grishanin RN, Yang H, Liu X, et al. Retinal TrkB receptors regulate neural development in the inner, but not outer, retina. Mol Cell Neurosci. 2008;38:431–443.
37. Wong KY. A retinal ganglion cell that can signal irradiance continuously for 10 hours. J Neurosci. 2012;32:11478–11485.
38. Rao S, Chun C, Fan J, et al. A direct and melanopsin-dependent fetal light response regulates mouse eye development. Nature. 2013;494:243–246.
39. Aad G, Abajyan T, Abbott B, et al. Search for dark matter in events with a hadronically decaying Wor Z boson and missing transverse momentum in pp collisions at s=8 TeV with the ATLAS detector. Phys Rev Lett. 2014;112:041802.
40. Joyal JS, Omri S, Sitaras N, Rivera JC, Sapieha P, Chemtob S. Neovascularization in retinopathy of prematurity: opposing actions of neuronal factors GPR91 and semaphorins 3A. Acta Paediatr. 2012;101(8):819–826.
41. Bahr M. Live or let die - retinal ganglion cell death and survival during development and in the lesioned adult CNS. Trends Neurosci. 2000;23:483–490.
42. Yang MB, Rao S, Copenhagen DR, Lang RA. Length of day during early gestation as a predictor of risk for severe retinopathy of prematurity. Ophthalmology. 2013;120:2706–2713.
43. Rao R, Mashburn CB, Mao J, Wadhwa N, Smith GM, Desai NS. Brain-derived neurotrophic factor in infants <32 weeks gestational age: correlation with antenatal factors and postnatal outcomes. Pediatr Res. 2009;65:548–552.
44. Hellgren G, Willett K, Engstrom E, et al. Proliferative retinopathy is associated with impaired increase in BDNF and RANTES expression levels after preterm birth. Neonatology. 2010;98:409–418.